130 related articles for article (PubMed ID: 19620706)
1. Effect of inhibition of neuropathy target esterase in mouse nervous tissues in vitro on phosphatidylcholine and lysophosphatidylcholine homeostasis.
Hou WY; Long DX; Wu YJ
Int J Toxicol; 2009; 28(5):417-24. PubMed ID: 19620706
[TBL] [Abstract][Full Text] [Related]
2. The homeostasis of phosphatidylcholine and lysophosphatidylcholine was not disrupted during tri-o-cresyl phosphate-induced delayed neurotoxicity in hens.
Hou WY; Long DX; Wang HP; Wang Q; Wu YJ
Toxicology; 2008 Oct; 252(1-3):56-63. PubMed ID: 18755237
[TBL] [Abstract][Full Text] [Related]
3. The homeostasis of phosphatidylcholine and lysophosphatidylcholine in nervous tissues of mice was not disrupted after administration of tri-o-cresyl phosphate.
Hou WY; Long DX; Wu YJ
Toxicol Sci; 2009 Jun; 109(2):276-85. PubMed ID: 19349639
[TBL] [Abstract][Full Text] [Related]
4. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy.
Milatovic D; Moretto A; Osman KA; Lotti M
Chem Res Toxicol; 1997 Sep; 10(9):1045-8. PubMed ID: 9305588
[TBL] [Abstract][Full Text] [Related]
5. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors.
Wu SY; Casida JE
Toxicol Appl Pharmacol; 1996 Jul; 139(1):195-202. PubMed ID: 8685903
[TBL] [Abstract][Full Text] [Related]
6. The search of the target of promotion: Phenylbenzoate esterase activities in hen peripheral nerve.
Moretto A; Nicolli A; Lotti M
Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):196-201. PubMed ID: 17207828
[TBL] [Abstract][Full Text] [Related]
7. Kinetic interactions of a neuropathy potentiator (phenylmethylsulfonyl fluoride) with the neuropathy target esterase and other membrane bound esterases.
Mangas I; Vilanova E; Estévez J
Arch Toxicol; 2014 Feb; 88(2):355-66. PubMed ID: 24071788
[TBL] [Abstract][Full Text] [Related]
8. Discrimination of carboxylesterases of chicken neural tissue by inhibition with a neuropathic, non-neuropathic organophosphorus compounds and neuropathy promoter.
Céspedes MV; Escudero MA; Barril J; Sogorb MA; Vicedo JL; Vilanova E
Chem Biol Interact; 1997 Oct; 106(3):191-200. PubMed ID: 9413546
[TBL] [Abstract][Full Text] [Related]
9. Phenylmethylsulfonyl fluoride, a potentiator of neuropathy, alters the interaction of organophosphorus compounds with soluble brain esterases.
Mangas I; Vilanova E; Estévez J
Chem Res Toxicol; 2012 Nov; 25(11):2393-401. PubMed ID: 23009703
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride.
Pope CN; Padilla S
J Toxicol Environ Health; 1990 Dec; 31(4):261-73. PubMed ID: 2254952
[TBL] [Abstract][Full Text] [Related]
11. The phosphorothioic acid O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase.
Moretto A; Bertolazzi M; Lotti M
Toxicol Appl Pharmacol; 1994 Nov; 129(1):133-7. PubMed ID: 7974486
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of the inhibitory interaction of organophosphorus neuropathy inducers and non-inducers in soluble esterases in the avian nervous system.
Mangas I; Vilanova E; Estévez J
Toxicol Appl Pharmacol; 2011 Nov; 256(3):360-8. PubMed ID: 21600909
[TBL] [Abstract][Full Text] [Related]
13. Bovine chromaffin cell cultures as model to study organophosporus neurotoxicity.
Quesada E; Sogorb MA; Vilanova E; Carrera V
Toxicol Lett; 2004 Jun; 151(1):163-70. PubMed ID: 15177651
[TBL] [Abstract][Full Text] [Related]
14. Interactions of neuropathy inducers and potentiators/promoters with soluble esterases.
Estévez J; Mangas I; Sogorb MÁ; Vilanova E
Chem Biol Interact; 2013 Mar; 203(1):245-50. PubMed ID: 23200747
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: toxicological implications.
Quistad GB; Sparks SE; Segall Y; Nomura DK; Casida JE
Toxicol Appl Pharmacol; 2002 Feb; 179(1):57-63. PubMed ID: 11884237
[TBL] [Abstract][Full Text] [Related]
16. NTE and non-NTE esterases in brain membrane: kinetic characterization with organophosphates.
Mangas I; Vilanova E; Estévez J
Toxicology; 2012 Jul; 297(1-3):17-25. PubMed ID: 22503708
[TBL] [Abstract][Full Text] [Related]
17. Soluble phenyl valerate esterases of hen sciatic nerve and the potentiation of organophosphate induced delayed polyneuropathy.
Gambalunga A; Pasqualato F; Lotti M
Chem Biol Interact; 2010 Sep; 187(1-3):340-3. PubMed ID: 20097189
[TBL] [Abstract][Full Text] [Related]
18. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy.
Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML
Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998
[TBL] [Abstract][Full Text] [Related]
19. Chromatographic discrimination of soluble neuropathy target esterase isoenzymes and related phenyl valerate esterases from chicken brain, spinal cord, and sciatic nerve.
Escudero MA; Céspedes MV; Vilanova E
J Neurochem; 1997 May; 68(5):2170-6. PubMed ID: 9109545
[TBL] [Abstract][Full Text] [Related]
20. Tri-ortho-cresyl phosphate induced neurotarget esterase inhibition in brain and peripheral nerve effectively monitored by lymphocytes.
Nanda S; Tapaswi PK
Indian J Exp Biol; 1994 May; 32(5):356-9. PubMed ID: 7927531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
